Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Clinical trial NCT04919642 · COMPLETED

Trial details

NCT number: NCT04919642
Sponsor: TransThera Sciences (Nanjing), Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma FGFR2 Fusion FGFR2 Gene Mutation FGFR1 Alteration FGFR3 Alteration

Start date: 2021-12-07
Primary completion: 2024-02-28
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.